ePrints

Phase II clinical and pharmacokinetic study of exatecan mesylate (DX-8951f) in patients with advanced ovarian cancer, refractory to, or relapsed after platinum and taxane.

Lookup NU author(s): Dr Paula Calvert, Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Calvert, P., Jayson, G., Atkinson, R., Ganesan, T., Cervantes-Ruiperez, A., Vasey, P., Adams, M., Boven, E., Calvert, A. H., Cheverton, P.

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 25th Anniversary ESMO Congress

Year of Conference: 2000

Pages: 84 no. 372

Publisher: Annals of Oncology: Oxford University Press

URL: http://dx.doi.org/10.1093/annonc/11.suppl_4.81

DOI: 10.1093/annonc/11.suppl_4.81

Library holdings: Search Newcastle University Library for this item

ISBN:

Share